Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors.

Fjallskog ML, Janson ET, Falkmer UG, Vatn MH, Oberg KE, Eriksson BK.

Neuroendocrinology. 2008;88(1):53-8. doi: 10.1159/000117575. Epub 2008 Feb 18.

PMID:
18285678
2.

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.

Kouvaraki MA, Ajani JA, Hoff P, Wolff R, Evans DB, Lozano R, Yao JC.

J Clin Oncol. 2004 Dec 1;22(23):4762-71. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15570077
3.

Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors.

Eriksson B, Skogseid B, Lundqvist G, Wide L, Wilander E, Oberg K.

Cancer. 1990 May 1;65(9):1883-90.

4.
5.

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors.

Fjällskog ML, Granberg DP, Welin SL, Eriksson C, Oberg KE, Janson ET, Eriksson BK.

Cancer. 2001 Sep 1;92(5):1101-7.

PMID:
11571721
6.

Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.

Mlineritsch B, Schabel-Moser R, Andel J, Fridrik M, Moik M, Mayer P, Russ G, Rass C, Greil R; Arbeitsgemeinschaft medikamentöse Tumortherapie Study Group.

Onkologie. 2009 Feb;32(1-2):18-24. doi: 10.1159/000180915. Epub 2009 Jan 20.

PMID:
19209014
7.

Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.

McCollum AD, Kulke MH, Ryan DP, Clark JW, Shulman LN, Mayer RJ, Bartel S, Fuchs CS.

Am J Clin Oncol. 2004 Oct;27(5):485-8.

PMID:
15596916
8.

The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?

Delaunoit T, Ducreux M, Boige V, Dromain C, Sabourin JC, Duvillard P, Schlumberger M, de Baere T, Rougier P, Ruffie P, Elias D, Lasser P, Baudin E.

Eur J Cancer. 2004 Mar;40(4):515-20.

PMID:
14962717
9.

Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.

Trudeau ME, Clemons MJ, Provencher L, Panasci L, Yelle L, Rayson D, Latreille J, Vandenberg T, Goel R, Zibdawi L, Rahim Y, Pouliot JF.

J Clin Oncol. 2009 Dec 10;27(35):5906-10. doi: 10.1200/JCO.2009.22.7504. Epub 2009 Oct 26.

PMID:
19858391
10.

Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?

Maire F, Hammel P, Kianmanesh R, Hentic O, Couvelard A, Rebours V, Zappa M, Raymond E, Sauvanet A, Louvet C, Lévy P, Belghiti J, Ruszniewski P.

Surgery. 2009 Jan;145(1):69-75. doi: 10.1016/j.surg.2008.08.007. Epub 2008 Sep 19.

PMID:
19081477
11.

Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy.

Strosberg J, Hoffe S, Gardner N, Choi J, Kvols L.

Neuroendocrinology. 2007;85(4):216-20. Epub 2007 May 16.

PMID:
17541257
12.

Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.

de Baere T, Deschamps F, Teriitheau C, Rao P, Conengrapht K, Schlumberger M, Leboulleux S, Baudin E, Hechellhammer L.

J Vasc Interv Radiol. 2008 Jun;19(6):855-61. doi: 10.1016/j.jvir.2008.01.030. Epub 2008 Mar 19.

PMID:
18503899
13.

Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.

Bukowski RM, Schacter LP, Groppe CW, Hewlett JS, Weick JK, Livingston RB.

Cancer. 1982 Jul 15;50(2):197-200.

14.
15.

A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancer.

Rose PG, Smrekar M, Haba P, Fusco N, Rodriguez M.

Am J Clin Oncol. 2008 Oct;31(5):476-80. doi: 10.1097/COC.0b013e31816a6221.

PMID:
18838885
16.

A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.

Frame J, Kelsen D, Kemeny N, Cheng E, Niedzwiecki D, Heelan R, Lippermann R.

Am J Clin Oncol. 1988 Aug;11(4):490-5.

PMID:
2841843
17.

Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.

Pectasides D, Pectasides E, Papaxoinis G, Xiros N, Sykiotis C, Papachristodoulou A, Tountas N, Panayiotides J, Economopoulos T.

Gynecol Oncol. 2008 Sep;110(3):299-303. doi: 10.1016/j.ygyno.2008.05.017. Epub 2008 Jul 7.

PMID:
18602677
18.

An update of the medical treatment of malignant endocrine pancreatic tumors.

Eriksson B, Oberg K.

Acta Oncol. 1993;32(2):203-8.

PMID:
8391832
19.

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.

Sonneveld P, Hajek R, Nagler A, Spencer A, Bladé J, Robak T, Zhuang SH, Harousseau JL, Orlowski RZ; DOXIL-MMY-3001 Study Investigators.

Cancer. 2008 Apr 1;112(7):1529-37. doi: 10.1002/cncr.23326.

Supplemental Content

Support Center